igf-1 lr3 side effects and risks Application benefits of LR3_Chemicalbook Late-life targeting of the IGF-1
Description
CXCL14 maintains hESC self-renewal through binding to IGF-1R and activation of the IGF-1R pathway

Tohoku J Exp Med 198 : 7177

A feasibility study
